• LPS Protection of Macrophages via System Xc− and ABCC1

  2026-09-17

  The reference study shows that lipopolysaccharide selectively protects macrophages from antitumor drug-induced damage without producing the same protection in tumor cells. Its experiments connect this effect to system Xc−-dependent glutathione synthesis and ABCC1-associated drug transport, providing a mechanistic framework for studying immune-cell preservation during chemotherapy.

• T0070907: A Practical PPARγ Antagonist Workflow

  2026-09-17

  T0070907 is a high-affinity, covalent PPARγ antagonist for separating receptor-dependent transcription from downstream cellular phenotypes. This workflow connects reporter assays, adipogenesis inhibition, RXRα/PPARγ pathway testing, and cancer cell-cycle experiments with practical controls and troubleshooting.

• Lysosomal β-Galactosidase Staining Kit

  2026-09-16

  Learn how Lysosomal β-Galactosidase Staining Kit K2181 can clarify lysosomal acidic β-galactosidase activity in senescence, viability, and cytotoxicity workflows. Scenario-based guidance addresses assay interpretation, material compatibility, protocol control, data comparison, and practical product selection.

• Pentoxifylline: From cAMP to Translation

  2026-09-16

  Pentoxifylline is more than a catalog phosphodiesterase inhibitor: it is a mechanistic probe for connecting cAMP regulation with TLR4 signaling, cytokine control, and cell-state changes. This thought-leadership guide translates evidence from preterm-infant monocytes into practical assay design, competitive positioning, and translational strategy.

• Cl-Amidine: A Causal PAD4 Lens on AML

  2026-09-15

  Cl-Amidine enables a controlled test of PAD4-dependent histone citrullination alongside AML transcriptional circuitry. This article translates the LMO2/LDB1 findings into a rigorous assay strategy while defining what PAD4 inhibition can—and cannot—establish in cancer research, inflammatory disease, and sepsis models.

• Urolithin A for Mitochondrial and Fibrosis Research

  2026-09-15

  Build a controlled Urolithin A workflow that connects mitophagy, mitochondrial respiration, and metabolic phenotyping without overstating antifibrotic evidence. The approach combines practical formulation guidance with the SIRT4–GDH findings that make glutamine metabolism a valuable comparator axis in hepatic stellate cell studies.

• Scutellaria Flavone 2′-Glucosides: Study Analysis

  2026-09-14

  The 1995 reference study isolated two previously unreported 2′-O-glucosylated flavones from Scutellaria baicalensis roots and established their structures using chromatography and spectroscopic analysis. Its identification of baicalin methyl ester as a known constituent provides important phytochemical context, while also showing why isolation evidence should be distinguished from later studies of intestinal inflammation and barrier biology.

• Radiopathomics Predicts Gastric Cancer Immunotherapy

  2026-09-14

  A multicenter study developed an interpretable radiopathomics signature by integrating baseline CT and digital H&E pathology images to predict response to immunotherapy-based combination therapy in gastric cancer. Its strong internal and external discrimination, prognostic stratification, and immune-related biological associations support multimodal biomarkers as a complement to conventional tissue and molecular markers, while validation and causal limitations remain important.

• DDI2–NFE2L1 Protects Cells from Ferroptosis

  2026-09-13

  The reference study identifies DDI2-mediated activation of NFE2L1 as an adaptive proteostasis response that restores proteasome function during ferroptotic stress. Its proteomic, genetic, and pharmacological evidence shows that disabling this pathway increases ubiquitylation, reduces proteasomal activity, and sensitizes cells to ferroptosis, providing a mechanistic framework for future cancer research.

• Isoprinosine in HSV-1 Research Workflows

  2026-09-12

  Build antiviral assays that separate direct viral suppression from immune modulation, while using CLCC1-linked nuclear egress phenotypes to sharpen mechanistic interpretation. This workflow positions inosine pranobex for dose-response, combination, imaging, and viral-titer studies without overstating an unproven CLCC1 target relationship.

• Recombinant Human FGF-19 for AKI Assays

  2026-09-11

  Build reproducible FGF-19/FGFR4 signaling and metabolic assays with a tag-free, activity-validated protein. This workflow also shows how to introduce FGF-19 as a controlled exploratory variable in sepsis-associated kidney injury models without overstating the current evidence.

• Pomalidomide (CC-4047) in Myeloma Research

  2026-09-11

  Pomalidomide, also called CC-4047, is an immunomodulatory compound used in hematological malignancy research. Reported benchmarks include inhibition of LPS-induced TNF-α release at 13 nM, increased HbF production in human erythroid progenitor cells at 1 μM, and reduced tumor growth in murine CNS lymphoma models after oral dosing.

• Entecavir (BMS200475) HBV Assay Workflow

  2026-09-10

  Build a resistance-aware HBV replication assay around Entecavir, from DMSO stock preparation through viral DNA and cccDNA readouts. This workflow combines nanomolar potency with longitudinal study design, helping distinguish genuine antiviral activity from cytotoxicity, formulation artifacts, and pre-existing resistance.

• Standardized Whole-Blood Stimulation in Immunometabolism

  2026-09-10

  Zhao and colleagues present a standardized whole-blood stimulation protocol for measuring how metabolic interventions reshape human immune responses. The framework combines defined innate immune stimuli, metabolic modulation, and cytokine quantification, offering a practical bridge between immunometabolism research and translational immune-function studies.

• Hydroxychloroquine Sulfate: Workflow Guide

  2026-09-09

  Hydroxychloroquine Sulfate is an aqueous-compatible research reagent for probing autophagy pathway modulation and TLR7/9-dependent immune responses in autoimmune disease research. It is suited to freshly prepared, short-term water-based workflows, but should not be selected for protocols requiring DMSO or ethanol solubility or long-term storage of prepared solutions.

8480 records 1/566 page Next 12345 下5页 Last page